SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-341032
Filing Date
2017-11-13
Accepted
2017-11-13 16:52:51
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d477343d10q.htm 10-Q 548394
2 EX-31.1 d477343dex311.htm EX-31.1 9173
3 EX-31.2 d477343dex312.htm EX-31.2 9113
4 EX-32.1 d477343dex321.htm EX-32.1 7625
  Complete submission text file 0001193125-17-341032.txt   3388329

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krys-20170930.xml EX-101.INS 514837
6 XBRL TAXONOMY EXTENSION SCHEMA krys-20170930.xsd EX-101.SCH 36689
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krys-20170930_cal.xml EX-101.CAL 42807
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krys-20170930_def.xml EX-101.DEF 154713
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20170930_lab.xml EX-101.LAB 332062
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20170930_pre.xml EX-101.PRE 265574
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 171196708
SIC: 2836 Biological Products, (No Diagnostic Substances)